Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous adipose-derived mesenchymal stem cells (Institute of Biophysics and Cell Engineering)
- Development stage
- Unknown
- Lead developer
- Institute of Biophysics and Cell Engineering
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Parenteral
01
Overview
Autologous adipose-derived mesenchymal stem cells (AD-MSCs) is a cell therapy being developed by the Institute of Biophysics and Cell Engineering of the National Academy of Sciences of Belarus for the treatment of urinary incontinence, particularly in men following prostatectomy. The therapy involves the isolation of mesenchymal stem cells from the patient's own adipose tissue, which are then expanded and mixed with a collagen gel. This mixture is injected submucosally into the urethral area to promote tissue regeneration and improve the structural integrity and function of the urinary sphincter. The collagen gel acts as a scaffold to support the survival and integration of the stem cells at the injection site.
- Other names
- autologous AD-MSCsautologous adipose-derived mesenchymal stem cells mixed with collagen gel
Beyond the preview
Go deeper on autologous adipose-derived mesenchymal stem cells (Institute of Biophysics and Cell Engineering).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous adipose-derived mesenchymal stem cells (Institute of Biophysics and Cell Engineering).